Healio Rheumatology—November 19, 2017
As the U.S. health care system changes and shifts its focus to value-based care, HSS rheumatologist Allan Gibofsky, MD discussed how he manages care for patients in the print cover story of Healio Rheumatology.
"Now we can readily measure the money spent, but it is more difficult to measure the worth or value to the patient. Consequently, when we’re evaluating value-based care, we often default to just measuring money," said Dr. Gibofsky.
"All stakeholders need to be informed about why certain decisions are being made. When decisions are made solely on the basis of cost, it is important for the prescriber to be aware of it…. We need to get to a consensus that prescribers should be making prescription decisions. These decisions should be based on clinical factors and not solely cost of care. The more we put the responsibility of decision-making in hands of doctors, the better it is for patients," he added.
Read the full article at healio.com. This article also appeared as the cover story in the November 2017 print edition.